These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8861540)

  • 1. Aluminium-induced bone disease in uremic rats: effect of deferoxamine.
    Jablonski G; Klem KH; Danielsen CC; Mosekilde L; Gordeladze JO
    Biosci Rep; 1996 Feb; 16(1):49-63. PubMed ID: 8861540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats.
    Jablonski G; Mortensen BM; Klem KH; Mosekilde L; Danielsen CC; Gordeladze JO
    Calcif Tissue Int; 1995 Nov; 57(5):385-91. PubMed ID: 8564802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption.
    Jablonski G; Danielsen CC; Mosekilde L; Gordeladze JO
    Calcif Tissue Int; 1994 Oct; 55(4):281-7. PubMed ID: 7820779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D, desferrioxamine and aluminum-induced bone disease in uremic rats.
    Verbeelen D; Smeyers-Verbeke J; van Hooff I; de Roy G
    Nephron; 1989; 53(1):54-60. PubMed ID: 2779702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia.
    Finch JL; Bergfeld M; Martin KJ; Chan YL; Teitelbaum S; Slatopolsky E
    Kidney Int; 1986 Sep; 30(3):318-24. PubMed ID: 3784278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.
    Slatopolsky E; Cozzolino M; Lu Y; Finch J; Dusso A; Staniforth M; Wein Y; Webster J
    Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgically induced uremia in rats. I: Effect on bone strength and metabolism.
    Jablonski G; Klem KH; Attramadal A; Dahl E; Rønningen H; Gautvik KM; Haug E; Gordeladze JO
    Biosci Rep; 1993 Oct; 13(5):275-87. PubMed ID: 8142613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminium-related osteodystrophy and desferrioxamine treatment: role of phosphorus.
    Jorgetti V; Soeiro NM; Mendes V; Pereira RC; Crivellari ME; Coutris G; Borelli A; Leite MO; Nussenzweig I; Marcondes M
    Nephrol Dial Transplant; 1994; 9(6):668-74. PubMed ID: 7970094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental aluminum intoxication and parathormone: effects on the mineralization process.
    Ballanti P; Mocetti P; Della Rocca C; Bonucci E; Costantini S; Giordano R; Ioppolo A; Mantovani A
    Miner Electrolyte Metab; 1989; 15(4):233-40. PubMed ID: 2761490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia.
    Ishii H; Wada M; Furuya Y; Nagano N; Nemeth EF; Fox J
    Bone; 2000 Feb; 26(2):175-82. PubMed ID: 10678413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum-related bone disease.
    Mazzaferro S; Coen G; Ballanti P; Costantini S; Bondatti F; Giordano R; Manni M; Pasquali M; Perruzza I; Sardella D
    Nephron; 1992; 61(2):151-7. PubMed ID: 1630538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus-dependent model of uremic osteomalacia in rats.
    Lieuallen WG; Weisbrode SE
    J Bone Miner Res; 1991 Jul; 6(7):751-7. PubMed ID: 1950679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of parathyroid hormone (PTH) and 24,25-dihydroxy-vitamin D3 on adenylyl cyclase of iliac crest biopsies: diagnostic and prognostic tool for evaluation and treatment of uremic patients.
    Gordeladze JO; Mortensen B; Nordal K; Halse J; Dahl E; Aksnes L; Gautvik KM
    Scand J Clin Lab Invest Suppl; 1987; 186():13-20. PubMed ID: 3496656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aluminium on the development of hyperparathyroidism and bone disease in the azotaemic rat.
    Felsenfeld AJ; Machado L; Bover J; Trinidad P; Rodriguez M
    Nephrol Dial Transplant; 1993; 8(4):325-34. PubMed ID: 8390007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of desferrioxamine on concentration and distribution of aluminum in bone.
    Verbeelen D; Smeyers-Verbeke J; Van Hooff I; Van der Straeten A; De Roy G
    Kidney Int; 1986 Jul; 30(1):68-73. PubMed ID: 3747345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.
    Felsenfeld AJ; Rodriguez M; Coleman M; Ross D; Llach F
    Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc nutritional status modifies renal osteodystrophy in uremic rats.
    Kimmel PL; Langman CB; Bognar B; Faugere MC; Chawla LS; Watkins DW; Malluche HH
    Clin Nephrol; 2001 Dec; 56(6):445-58. PubMed ID: 11770796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.